In a recent study in Journal of Proteome Research by Human Protein Atlas-researchers a new reactive epitope of a prostate specific protein, particularly reactive in the late stages of prostate cancer is identified.
According to WHO, prostate cancer is the second most incident cancer in men and the fifth leading cause of death in men worldwide, and there is a demand for novel targets and approaches to diagnose and treat this cancer type. Five-year survival is reached by almost 100% of patients if the disease is still at a local and regional stage; however, the survival rate drops down to 30% in the case of aggressive form with distant metastasis and relapse after treatment...Read more
Novel biomarkers for prostate cancer found while defining the prostate specific transcriptome and proteomeTo better understand the function of the prostate and diseases associated with it, it is important to explore the molecular constituents that make up the prostate gland.
In a recent study by scientists from the Human Protein Atlas project and colleagues both gene and protein expression profiles were investigated in prostate tissue and compared to 26 other human tissues. The aim was to identify potential prostate specific biomarkers for potential clinical use...Read more
October 24, 2018 - October 28, 2018
Mathias Uhlen will present "The creation of a mammalian protein brain atlas" at the 13th International Conference on Genomics taking place in Shenzhen, China. His talk is scheduled at 15.20 on October 26. Programme
October 25, 2018 - October 26, 2018
Dr. Jochen Schwenk will give a talk on "Affinity-based assays for biomarkers of the plasma proteome", at the 14th Annual Workshop of Biofilms - Research Center for Biointerfaces, which focuses on Biomarkers - methods and technology.Programme